Annual ROE:
19.23%+0.96%(+5.25%)Summary
- As of today, UTHR annual return on equity is 19.23%, with the most recent change of +0.96% (+5.25%) on December 31, 2024.
- During the last 3 years, UTHR annual ROE has risen by +6.29% (+48.61%).
- UTHR annual ROE is now -57.91% below its all-time high of 45.69%, reached on December 31, 2015.
Performance
UTHR ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
19.20%-0.07%(-0.36%)Summary
- As of today, UTHR quarterly return on equity is 19.20%, with the most recent change of -0.07% (-0.36%) on September 30, 2025.
- Over the past year, UTHR quarterly ROE has dropped by -0.06% (-0.31%).
- UTHR quarterly ROE is now -70.86% below its all-time high of 65.90%, reached on June 30, 2016.
Performance
UTHR Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
UTHR ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +5.3% | -0.3% |
| 3Y3 Years | +48.6% | +13.1% |
| 5Y5 Years | +614.2% | +21.4% |
UTHR ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +48.6% | -5.0% | +21.1% |
| 5Y | 5-Year | at high | +614.2% | -5.0% | +53.1% |
| All-Time | All-Time | -57.9% | +120.2% | -70.9% | +124.3% |
UTHR ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | 19.20%(-0.4%) |
| Jun 2025 | - | 19.27%(-3.3%) |
| Mar 2025 | - | 19.92%(-1.4%) |
| Dec 2024 | 19.23%(+5.3%) | 20.21%(+4.9%) |
| Sep 2024 | - | 19.26%(+1.4%) |
| Jun 2024 | - | 19.00%(-0.3%) |
| Mar 2024 | - | 19.05%(+4.6%) |
| Dec 2023 | 18.27%(+10.0%) | 18.22%(+3.7%) |
| Sep 2023 | - | 17.57%(-2.4%) |
| Jun 2023 | - | 18.00%(+13.6%) |
| Mar 2023 | - | 15.85%(-4.9%) |
| Dec 2022 | 16.61%(+28.4%) | 16.67%(-1.8%) |
| Sep 2022 | - | 16.97%(+7.2%) |
| Jun 2022 | - | 15.83%(-12.3%) |
| Mar 2022 | - | 18.04%(+38.6%) |
| Dec 2021 | 12.94%(-22.4%) | 13.02%(-0.9%) |
| Sep 2021 | - | 13.14%(-5.9%) |
| Jun 2021 | - | 13.97%(+11.4%) |
| Mar 2021 | - | 12.54%(-24.5%) |
| Dec 2020 | 16.67%(+545.7%) | 16.61%(+5.1%) |
| Sep 2020 | - | 15.81%(+3.7%) |
| Jun 2020 | - | 15.24%(-22.9%) |
| Mar 2020 | - | 19.77%(+599.2%) |
| Dec 2019 | -3.74%(-115.6%) | -3.96%(-13.5%) |
| Sep 2019 | - | -3.49%(+22.8%) |
| Jun 2019 | - | -4.52%(+22.6%) |
| Mar 2019 | - | -5.84%(-125.0%) |
| Dec 2018 | 23.91%(+14.0%) | 23.35%(+2.3%) |
| Sep 2018 | - | 22.82%(-29.7%) |
| Jun 2018 | - | 32.46%(+40.5%) |
| Mar 2018 | - | 23.10%(+9.9%) |
| Dec 2017 | 20.98%(-49.1%) | 21.01%(-20.2%) |
| Sep 2017 | - | 26.32%(+25.4%) |
| Jun 2017 | - | 20.99%(-40.4%) |
| Mar 2017 | - | 35.21%(-12.7%) |
| Dec 2016 | 41.23%(-9.8%) | 40.32%(-3.6%) |
| Sep 2016 | - | 41.81%(-36.6%) |
| Jun 2016 | - | 65.90%(+1.4%) |
| Mar 2016 | - | 64.98%(+29.3%) |
| Dec 2015 | 45.69%(+69.5%) | 50.25%(-7.9%) |
| Sep 2015 | - | 54.55%(+264.2%) |
| Jun 2015 | - | 14.98%(-2.3%) |
| Mar 2015 | - | 15.34%(-43.8%) |
| Dec 2014 | 26.95%(+82.6%) | 27.31%(+76.0%) |
| Sep 2014 | - | 15.52%(-31.4%) |
| Jun 2014 | - | 22.62%(+12.4%) |
| Mar 2014 | - | 20.12%(+37.7%) |
| Dec 2013 | 14.76%(-50.5%) | 14.61%(-41.4%) |
| Sep 2013 | - | 24.94%(-9.2%) |
| Jun 2013 | - | 27.47%(-0.1%) |
| Mar 2013 | - | 27.49%(-6.6%) |
| Dec 2012 | 29.80% | 29.44%(+15.0%) |
| Sep 2012 | - | 25.61%(-2.3%) |
| Jun 2012 | - | 26.21%(-2.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | 26.87%(+21.6%) |
| Dec 2011 | 23.71%(+72.1%) | 22.10%(+16.0%) |
| Sep 2011 | - | 19.05%(+21.0%) |
| Jun 2011 | - | 15.74%(+26.6%) |
| Mar 2011 | - | 12.43%(-8.7%) |
| Dec 2010 | 13.78%(+311.3%) | 13.62%(+6.7%) |
| Sep 2010 | - | 12.77%(+33.4%) |
| Jun 2010 | - | 9.57%(+143.5%) |
| Mar 2010 | - | 3.93%(+20.6%) |
| Dec 2009 | 3.35%(+131.5%) | 3.26%(+130.7%) |
| Sep 2009 | - | -10.62%(+8.9%) |
| Jun 2009 | - | -11.66%(-24.8%) |
| Mar 2009 | - | -9.34%(+16.5%) |
| Dec 2008 | -10.65%(-234.1%) | -11.19%(-189.6%) |
| Sep 2008 | - | 12.49%(-19.3%) |
| Jun 2008 | - | 15.48%(+6.8%) |
| Mar 2008 | - | 14.50%(+53.6%) |
| Dec 2007 | 7.94%(-74.3%) | 9.44%(-73.5%) |
| Sep 2007 | - | 35.57%(+19.0%) |
| Jun 2007 | - | 29.90%(+6.5%) |
| Mar 2007 | - | 28.07%(+1.7%) |
| Dec 2006 | 30.84%(+10.7%) | 27.61%(+58.4%) |
| Sep 2006 | - | 17.43%(-16.9%) |
| Jun 2006 | - | 20.97%(-14.3%) |
| Mar 2006 | - | 24.47%(-15.3%) |
| Dec 2005 | 27.86%(+224.0%) | 28.89%(+40.0%) |
| Sep 2005 | - | 20.64%(+20.3%) |
| Jun 2005 | - | 17.16%(+25.2%) |
| Mar 2005 | - | 13.71%(+55.3%) |
| Dec 2004 | 8.60%(+246.5%) | 8.83%(+182.1%) |
| Sep 2004 | - | 3.13%(+331.9%) |
| Jun 2004 | - | -1.35%(+74.2%) |
| Mar 2004 | - | -5.23%(+11.2%) |
| Dec 2003 | -5.87%(+54.3%) | -5.89%(-7.5%) |
| Sep 2003 | - | -5.48%(+52.8%) |
| Jun 2003 | - | -11.62%(+1.4%) |
| Mar 2003 | - | -11.78%(+8.5%) |
| Dec 2002 | -12.85%(+25.7%) | -12.87%(+14.0%) |
| Sep 2002 | - | -14.97%(-13.7%) |
| Jun 2002 | - | -13.17%(+19.3%) |
| Mar 2002 | - | -16.31%(+6.1%) |
| Dec 2001 | -17.30%(+67.0%) | -17.37%(+37.0%) |
| Sep 2001 | - | -27.57%(+3.6%) |
| Jun 2001 | - | -28.59%(+30.2%) |
| Mar 2001 | - | -40.98%(+16.6%) |
| Dec 2000 | -52.45%(+45.0%) | -49.13%(-11.1%) |
| Sep 2000 | - | -44.23%(+30.2%) |
| Jun 2000 | - | -63.35%(-34.7%) |
| Mar 2000 | - | -47.02%(+34.5%) |
| Dec 1999 | -95.40%(-23.9%) | -71.77%(-29.1%) |
| Sep 1999 | - | -55.60%(-12.0%) |
| Jun 1999 | - | -49.66%(+37.1%) |
| Mar 1999 | - | -78.95% |
| Dec 1998 | -76.97% | - |
FAQ
- What is United Therapeutics Corporation annual return on equity?
- What is the all-time high annual ROE for United Therapeutics Corporation?
- What is United Therapeutics Corporation annual ROE year-on-year change?
- What is United Therapeutics Corporation quarterly return on equity?
- What is the all-time high quarterly ROE for United Therapeutics Corporation?
- What is United Therapeutics Corporation quarterly ROE year-on-year change?
What is United Therapeutics Corporation annual return on equity?
The current annual ROE of UTHR is 19.23%
What is the all-time high annual ROE for United Therapeutics Corporation?
United Therapeutics Corporation all-time high annual return on equity is 45.69%
What is United Therapeutics Corporation annual ROE year-on-year change?
Over the past year, UTHR annual return on equity has changed by +0.96% (+5.25%)
What is United Therapeutics Corporation quarterly return on equity?
The current quarterly ROE of UTHR is 19.20%
What is the all-time high quarterly ROE for United Therapeutics Corporation?
United Therapeutics Corporation all-time high quarterly return on equity is 65.90%
What is United Therapeutics Corporation quarterly ROE year-on-year change?
Over the past year, UTHR quarterly return on equity has changed by -0.06% (-0.31%)